Weight Management Articles - Page 64

Study Flags Gut Risks from SNAC in Oral Weight-Loss Pills

A groundbreaking study from Adelaide University is raising questions about SNAC, the ingredient making oral weight-loss drugs like semaglutide tablets viable. In a 21-day animal model, repeated SNAC exposure linked to lower beneficial gut bacteria, reduced protective compounds, and elevated inflammation markers. As tablet versions gain popularity, experts call for more research on this component's full impact.

Shotlee·Feb 21, 2026·6 min read

GLP-1 Medications

GP's Surprising Mounjaro Effects: Weight Loss and Mood Shifts After 3 Months

A 33-year-old GP tried Mounjaro for obesity and was stunned by more than just weight loss—his 'food noise' vanished, alcohol interest dropped, and mood stabilized. After shedding almost two stone in three months, urges returned upon stopping, highlighting obesity's chronic nature. Now back on 5mg, he emphasizes long-term strategies beyond medication.

Shotlee·Feb 21, 2026·5 min read

GLP-1 Medications

Lost 32% Body Weight on Mounjaro: Mistakes to Avoid

A woman known as @cartcrushuk on TikTok dropped 32% of her body weight using Mounjaro fat jabs and is now sharing the 'Mounjaro mistakes' she made along the way. From wasting time before starting to struggling with hydration and before photos, her honest advice focuses on protein, fiber, and basics for success. Her video has inspired thousands with nearly 15,000 views in four days.

Shotlee·Feb 21, 2026·5 min read

Healthcare Investing

Forget Ozempic: Intuitive Surgical Thrives No Matter GLP-1 Winner

Wall Street fixates on GLP-1 giants like Novo Nordisk's Ozempic and Eli Lilly, but Intuitive Surgical continues to thrive with its da Vinci surgical robots. With 11,106 systems installed by end of 2025 and procedures up 18%, this device maker is set for growth regardless of the weight loss drug race. Learn why investors should consider ISRG shares.

Shotlee·Feb 20, 2026·5 min read

GLP-1 Medications

Study: Ozempic, Wegovy NAION Risk Twofold Higher vs. SGLT2i Drugs

New research from Veterans' Affairs shows Ozempic and Wegovy users face double the risk of NAION—a serious vision loss condition—compared to SGLT2i drugs. Published in JAMA Ophthalmology, the study urges doctors to warn patients about potential permanent blindness from semaglutide-based GLP-1 medications. As lawsuits mount, understand the implications for diabetes and weight management.

Shotlee·Feb 19, 2026·5 min read

GLP-1 Medications

Eli Lilly Grabs Biggest Slice of GLP-1 Gold Rush Over Ozempic

Eli Lilly has overtaken Novo Nordisk in the GLP-1 gold rush, with Mounjaro and Zepbound now holding 60% of the U.S. market versus Ozempic and Wegovy's 39%. Backed by blockbuster revenue growth and superior weight loss results in head-to-head studies, Lilly's tirzepatide drugs are reshaping obesity and diabetes treatment. Investors and patients alike are taking notice of this shift.

Shotlee·Feb 19, 2026·5 min read

GLP-1 Medications & Peptide Therapy

Leicester Doctor's Mounjaro Experience: Mental Changes & Advice

A Leicester doctor tried Mounjaro for obesity and was shocked by how it silenced his 'food noise' and curbed alcohol desires, alongside significant weight loss. But stopping brought cravings back fast. Discover his message on long-term use, side effects, and who should consider it.

Shotlee·Feb 19, 2026·5 min read

GLP-1 Medications

Pharmacist Warns Mounjaro Users: Holiday Travel Precautions

A superintendent pharmacist is urging Mounjaro users to take specific precautions when traveling on holiday, from buffet strategies to proper medication storage. Buffets pose unique challenges for GLP-1 users, and extreme temperatures in plane cargo holds can ruin pens. Get expert advice to keep your weight loss journey on track.

Shotlee·Feb 19, 2026·6 min read

GLP-1 Medications

Joy Behar Reveals GLP-1 Weight Loss: 'I Was Prediabetic' on The View

On The View, Joy Behar opened up about her GLP-1 weight loss success, noting she was prediabetic before starting. Co-host Sunny Hostin shared gaining 40 lbs during COVID and using Mounjaro to improve her cholesterol from 200 to 140. These stories highlight Hollywood's trend toward Ozempic and similar drugs for real health gains.

Shotlee·Feb 19, 2026·5 min read

Weight Management

Latest Articles

Study Flags Gut Risks from SNAC in Oral Weight-Loss Pills

GP's Surprising Mounjaro Effects: Weight Loss and Mood Shifts After 3 Months

Lost 32% Body Weight on Mounjaro: Mistakes to Avoid

Forget Ozempic: Intuitive Surgical Thrives No Matter GLP-1 Winner

Study: Ozempic, Wegovy NAION Risk Twofold Higher vs. SGLT2i Drugs

Eli Lilly Grabs Biggest Slice of GLP-1 Gold Rush Over Ozempic

Leicester Doctor's Mounjaro Experience: Mental Changes & Advice

Pharmacist Warns Mounjaro Users: Holiday Travel Precautions

Joy Behar Reveals GLP-1 Weight Loss: 'I Was Prediabetic' on The View

Ozempic, Mounjaro & More: Yale Study Exposes Risky Online GLP-1 Prescribing

Beyond Healthspan: The New Midlife Goal for Men

GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & Allodynia

Study Finds Some Patients Keep Weight Off with Fewer GLP-1 Injections

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less